Dimethylformamide → HCID 178508756, compound
Reaction equation
I[Si](C)(C)C.[NH2:6][C:7]1[C:8]([C:15](/[N:17]=[C:18]2\[NH:19][CH2:20][C:21]3([CH2:28][CH:27]4[N:29](C(OC(C)(C)C)=O)[CH:24]([CH2:25][CH2:26]4)[CH2:23]3)[NH:22]\2)=[O:16])=[N:9][C:10]([Cl:14])=[C:11]([NH2:13])[N:12]=1.CN(C=O)C>C(Cl)Cl>[NH2:6][C:7]1[C:8]([C:15](/[N:17]=[C:18]2\[NH:19][CH2:20][C:21]3([CH2:28][CH:27]4[NH:29][CH:24]([CH2:25][CH2:26]4)[CH2:23]3)[NH:22]\2)=[O:16])=[N:9][C:10]([Cl:14])=[C:11]([NH2:13])[N:12]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Iodotrimethylsilane (0.23 ml, 1.66 mmol) is added to a suspension of (E)-tert-Butyl 2′-(3,5-diamino-6-chloropyrazine-2-carbonylimino)-8-azaspiro[bicyclo[3.2.1]octane-3,4′-imidazolidine]-8-carboxylate (Ex. 251) (500 mg, 1.11 mmol) in DCM (10 ml). DMF (5 ml) is then added and the reaction is stirred at room temperature overnight. Iodotrimethylsilane (0.5 ml) is added and the reaction mixture is concentrated in vacuo. The yellow solid is suspended in DCM and collected by filtration. The solid is dissolved in 1:1 MeOH/DCM and loaded onto an SCX-2 cartridge eluted with DCM followed by MeOH and NH3/MeOH. The methanolic ammonia fractions are concentrated in vacuo to afford (E)-3,5-diamino-6-chloro-N-(8-azaspiro[bicyclo[3.2.1]octane-3,4′-imidazolidine]-2′-ylidene)pyrazine-2-carboxamide as a yellow gum; [M+H]+ 351
Workup
- concentrationthe reaction mixture is concentrated in vacuo
- filtrationcollected by filtration
- dissolutionThe solid is dissolved in 1:1 MeOH/DCM
- washeluted with DCM
- concentrationThe methanolic ammonia fractions are concentrated in vacuo
Sources & evidence
- ORD record
- ord-1d7f11b0bff847dab22e018b4a91faa3
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09139586B2
Reaction notes
Loading…